Buy Fluorouracil

Fluorouracil

Fluorouracil: Generic Medication Overview

Fluorouracil is a topical chemotherapy agent classified within skin-care and oncology support therapies. It is available in a tube formulation at concentrations of 1 % and 5 %. In Hong Kong, Fluorouracil is a prescription-only medication regulated by the Hong Kong Department of Health. The product is used primarily for the treatment of precancerous skin lesions and superficial skin cancers.

How Fluorouracil Works in the Body

Fluorouracil is an antimetabolite that interferes with DNA synthesis. After penetrating the skin, it is converted inside cells to fluorodeoxyuridine monophosphate (FdUMP). FdUMP binds irreversibly to the enzyme thymidylate synthase, blocking the conversion of deoxyuridine monophosphate to thymidine monophosphate. Without thymidine, cancerous cells cannot replicate DNA, leading to cell death. The drug acts locally, producing a cytotoxic effect limited to the treated area, which minimizes systemic exposure.

• Onset of action: Erythema and irritation typically appear within a few days of the first application.
• Peak effect: Maximal lesion response is observed after 2-4 weeks of continuous use.
• Duration: Lesion clearance may continue for several weeks after treatment stops, followed by re-epithelialisation.

Conditions Treated by Fluorouracil

Fluorouracil is approved in Hong Kong for the following dermatologic indications:

• Actinic keratosis (solar keratosis) - a precancerous lesion caused by chronic UV exposure.
• Superficial basal cell carcinoma - an early-stage skin cancer confined to the epidermis and upper dermis.

These indications are supported by clinical guidelines from the Hong Kong Dermatology Society and international dermatologic consensus statements. Fluorouracil is applied directly to the lesion(s) under the supervision of a qualified dermatologist or physician.

Patient Suitability and Contraindications

Who Should Use Fluorouracil?

• Adults with clinically diagnosed actinic keratosis or superficial basal cell carcinoma.
• Patients capable of following a prescribed topical regimen and attending follow-up appointments.
• Individuals without known hypersensitivity to fluorouracil or any excipients in the tube.

Absolute Contraindications

• Documented hypersensitivity to fluorouracil or any component of the formulation.
• Pregnancy (category D) - systemic absorption, although rare, may pose fetal risk.
• Lactation - drug may be present in breast milk; use is not recommended.

Relative Contraindications

• Severe immunosuppression (e.g., post-organ transplantation) - increased risk of infection at treatment sites.
• Large surface-area treatment (> 200 cm²) - may raise systemic absorption potential; monitor closely.
• Dermatologic conditions that compromise barrier function (e.g., eczema) in the treatment area.

Special caution is advised for elderly patients, as skin atrophy may enhance local irritation.

Safety Profile: Side Effects and Interactions

Common Side Effects

• Local irritation - redness, burning, or stinging sensation (commonly reported).
• Erythema and crusting - may develop 2-5 days after first application.
• Pruritus - itching often accompanies inflammation.

These reactions are typically transient and indicate that the medication is acting on abnormal cells.

Serious Adverse Events

• Severe ulceration or necrosis - extensive tissue breakdown requiring medical attention.
• Secondary infection - bacterial colonisation of ulcerated areas; may need topical or oral antibiotics.
• Systemic toxicity - very rare with topical use; signs would include nausea, vomiting, or bone-marrow suppression.

If any of these serious signs occur, discontinue use and seek immediate medical care.

Drug Interactions

• Topical irritants (e.g., salicylic acid, retinoids) applied concurrently may amplify skin irritation; space applications or avoid combined use.
• Systemic chemotherapy agents that also target thymidylate synthase could theoretically increase overall toxicity, though clinical significance with topical Fluorouracil is minimal.

Patients should disclose all current medications, supplements, and over-the-counter products to their healthcare provider before initiating therapy.

Food and Lifestyle Interactions

• No specific dietary restrictions are required.
• Alcohol consumption does not affect topical Fluorouracil but excessive drinking may impair wound healing.
• Sun exposure should be avoided on treated areas; use sunscreen on surrounding skin once lesions have healed.

How to Take Fluorouracil

• Standard dosing: Apply a thin layer of the 1 % or 5 % cream to the affected area once daily, usually at night, for 2-4 weeks. The exact concentration and duration depend on lesion size, thickness, and physician assessment.
• Application tips:
• Wash hands thoroughly before and after use.
• Clean the lesion gently; pat dry.
• Avoid applying to healthy surrounding skin; use a cotton swab if needed.
• Special populations:
• Renal or hepatic impairment: No dosage adjustment required for topical use, but monitor for systemic signs if large surface areas are treated.
• Elderly patients: May benefit from starting with the lower 1 % concentration to assess tolerance.
• Missed dose: Apply as soon as remembered unless it is close to the next scheduled dose; do not double the amount.
• Overdose: Systemic overdose is unlikely; however, extensive skin application may cause severe local toxicity. Seek medical attention if widespread ulceration or systemic symptoms develop.
• Discontinuation: Treatment can be stopped once lesions have resolved or if intolerable irritation occurs. No tapering is needed, but follow-up evaluation is recommended.

Monitoring and Follow-Up

• Clinical assessment: A physician should examine the treated area every 1-2 weeks to gauge response and adjust treatment length.
• Laboratory monitoring: Not required for standard topical regimens; systemic labs are only indicated if large surface areas are treated or if systemic toxicity is suspected.
• When to contact a provider: Rapid spreading of redness, severe pain, fever, or signs of infection.

Storage and Handling

• Store the tube at room temperature (15-30 °C), away from direct sunlight and moisture.
• Keep the container tightly closed when not in use.
• Do not use the product after the expiration date printed on the label.
• Keep out of reach of children and pets; consider a child-proof lock on the cabinet.

Medication-Specific Glossary

Actinic Keratosis

A rough, scaly patch on the skin caused by long-term ultraviolet exposure; considered a precursor to squamous cell carcinoma.

Basal Cell Carcinoma (Superficial Type)

A low-risk skin cancer confined to the outer skin layers, often appearing as a flat, reddish patch.

Thymidylate Synthase Inhibition

The process by which fluorouracil blocks an enzyme essential for DNA synthesis, leading to cell death in rapidly dividing cells.

Systemic Absorption (Topical)

The movement of a drug from the skin into the bloodstream; with fluorouracil, this is minimal when used on limited areas.

Medical Disclaimer

This article provides educational information about Fluorouracil and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.